Healthcare Industry Insights: March 2020

Tuesday 31 March 2020

Hearing Amplifiers Market: Industry Demand, Sales, Analysis and Forecasts to 2022

Global Hearing Amplifiers Market is expected to reach USD 78.2 million by 2022, according to a new study by Grand View Research Inc. Growing prevalence of deafness and hearing disorders and the increasing cost of hearing aids are expected to drive the hearing amplifiers market over the forecast period. Hearing amplifiers are relatively cheaper products and therefore, are more preferred in patients with manageable deafness severities. For instance, the ASP of hearing amplifier amounts to USD 200, as opposed to hearing aids priced at approximately USD 450 to 1,000. Rising R&D investments aimed at new product development in congruence with the changing consumer dynamics is expected to significantly contribute towards expedited market growth.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/hearing-amplifiers-market

Further key findings from the study suggest:

On the ear hearing amplifiers were the largest product segment of the market in 2014. The fact that, on the ear hearing amplifiers are comfortable to use, render high connectivity and are user-friendly is expected to drive segment growth over the forecast period.
In the ear hearing amplifiers are identified as the most lucrative product segment of the market. In the ear hearing amplifiers allow clear perception of surrounding voice as it blocks the entire ear cavity and prohibit the passage of the user’s own voice and this is expected to serve the segment as a driver. Moreover, these devices score high on the consumer preference matrix owing to their aesthetic appeal.
Asia Pacific is expected to spearhead future market growth. The increasing prevalence of deafness especially in the geriatric population and growing retail healthcare industry in emerging countries such as India and China are some factors attributing to region’s rapid market growth.
China is expected to witness the fastest growth over the forecast period. As per the National Bureau of Statistics of China, approximately 185 million are over the age of 60. According to the United Nations study of 2007, by 2025, 64 elderly for every 100 workers is the estimated ratio in China. In 2003, as per a study of the United Nations Children's Fund (UNICEF), approximately 10% of the population had hearing loss. The Second China National Survey on Disability by the China Disabled Persons' Federation (CDPF) identified 20.04 million people as “hearing impaired”. Growing population in China and introduction of technologically advanced devices are expected to drive the market over the forecast period.
Key players of the hearing amplifiers market include Resound, SoundHawk, Shenzhen LA Lighting Company Limited, Austar Hearing Science And Technology (Xiamen) Co., Ltd., Ziphearing and Huizhou Jinghao Electronics Co. Ltd.

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Orthobiologics Market Outlook and Forecast Report, 2025

The global Orthobiologics Market size is expected to reach USD 10.2 billion by 2025, at a CAGR of 7.5% according to a new study by Grand View Research, Inc. The orthobiologics industry trends is predominantly driven by the increasing orthopedic disease and musculoskeletal disease burden globally. Moreover, emerging technological innovations in biomaterials, used in the production of orthobiologics are presumed to accelerate the market demand over the forecast period and will help grow the competition among the key players, particularly in U.S. These predominantly include modifications in graft designs, advent of recombinant biologic agents, stem cell therapy and cultured tissue scaffolds.

These advancements are accompanied with the benefits such as enhanced biocompatibility, reduced surgical time and smaller incisions. Furthermore, these novel solutions are presumed to efficiently reduce the recurrence of post-operative complications, which in turn is expected to boost the orthobiologics device market during the forecast period.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/orthobiological-products-market

Further Key Findings From the Study Suggest:

In 2015, viscosupplementation accounted for the largest share in the product segment owing to being a cost efficient therapeutic alternative for symptomatic management of osteoarthritis
Spinal fusion held the largest share in the application segment in 2015, owing to presence of third party insurers and reimbursement structure for fusion enhancement products thus triggering growth
In 2015, North America accounted for the dominant share owing to consistent efforts of industry players in promoting awareness pertinent to the orthobiological products resulting in significant rise in adoption rate
Asia Pacific is anticipated to exhibit an exponential CAGR as a consequence of significant surge in healthcare spending and awareness levels with respect to the availability of orthobiologics
The prominent players are consistently indulging into extensive strategies to gain competitive position including regional expansion and mergers & acquisitions to capture a greater share of the orthobiologics market
For instance, in November 2015, Bioventus acquired BioStructures, a bioabsorbable bone graft developer. This acquisition was carried out to expand orthobiologics product portfolio and grafting solutions in order to expand their market share

Pulmonary Drug Delivery Systems Market: Current Trends and Future Opportunities

The global Pulmonary Drug Delivery Systems Market size is expected to reach USD 55.1 billion by 2025, according to a new report by Grand View Research, Inc., Increasing prevalence of chronic respiratory diseases is expected to boost the adoption of Pulmonary Drug Delivery Systems (PDDS). As per WHO, 235 million people suffer from asthma globally. Majority of the asthma related deaths occur in middle- to low-income countries due to lack of treatment options. This shows the potential demand for pulmonary drug delivery systems in the coming years.

Technological advancements in the field of drug delivery are expected to positively impact the pulmonary drug delivery devices market. These advancements include incorporation of agglomerated vesicle technology, MDI electronic dose counter, particle engineering, and supercritical fluid technology. Rising demand for new products, changing lifestyle, ease of use, and better facilities are factors expected to provide lucrative opportunities.

Furthermore, rise in number of public and private organizations is another major factor propelling the growth of pulmonary drug delivery devices market. For instance, organizations such as the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) are engaged in providing information in clinical and basic research on allergy, asthma, and clinical immunology. Such initiatives are in turn expected to increase the market demand for respiratory drug delivery devices in developing regions, thereby boosting overall market growth.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/pulmonary-drug-delivery-systems-market

Further Key Findings From the Study Suggest:

Metered dose inhaler segment held the dominant share owing to its low cost and high adoption rate due to early introduction in the market
Chronic Obstructive Pulmonary Diseases (COPD) segment is anticipated to grow at a lucrative CAGR due to the presence of favorable reimbursement policies for treatment of COPD
High number of patients affected by asthma in developing and developed regions is likely to support the development of asthma applications for respiratory drug delivery devices
E-commerce segment is expected to witness lucrative growth. Development of this segment is supported by its associated benefits such as convenience, discounts, and flexibility
Home care segment is expected to exhibit exponential growth due to the introduction of technologically advanced, portable, and small-sized devices that can be used at home
Asia Pacific region is anticipated to grow at a lucrative CAGR. High prevalence of COPD, indicating a substantial socioeconomic burden in this region drives the growth in Asia Pacific
The pulmonary drug delivery systems market is progressing due to the rising demand for better treatment options, efficient drug delivery, and rapid treatment of local respiratory disorders

Gas Chromatography Market Report | GE Healthcare; Shimadzu Corporation; Thermo Fisher Scientific, Inc.

The global Gas Chromatography Market size is anticipated to reach USD 4.3 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness a CAGR of 6.4% over the forecast period, owing to increasing government investments in chromatography technologies coupled with rising collaborations between chromatography manufacturers and research laboratories.

Government in some parts of the world are investing in the chromatography techniques. For instance, Government of Canada has invested into business innovation initiative that is likely to help southern Ontario companies such as Natrix Separations, Inc. for developing new ideas and take their innovations to market. This funding is expected to assist the company in designing a prototype and developing single-use membrane-based chromatography products for large-scale biopharmaceutical manufacturing.

Rising collaborations between chromatography manufacturers and research laboratories are gaining pace in order to develop, evaluate, and validate new methods. For instance, PerkinElmer, Inc., has collaborated with Waters, to get practical and sustainable scientific innovations in order to optimize laboratory operations and to meet regulatory compliance.

The research activities include application areas, such as food and natural product analysis, pharmaceutical analysis, chemistry, petrochemistry, polymer analysis, and environmental analysis. Additionally, Hichrom Limited, a UK-based company collaborated with the chromatographic instrument and column manufacturers, and academic institutes or groups, to provide method development support, chromatographic methodologies troubleshooting, and others.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/gas-chromatography-market

Further Key Findings From the Study Suggest:

The accessories & consumables segment held lucrative market share in 2016 and is expected to grow at a significant rate over the forecast period owing to growing demand for GC accessories as they have limited durability and repetitive use
The healthcare segment is expected to be the fastest growing segment over the forecast period due to increasing applications of gas chromatography for biopharmaceutical industries such as analysis of volatile and semi-volatile compounds, and identification of amount of chemicals in drugs
North America is expected to dominate the gas chromatography market over the forecast period due to increasing Canadian government investment in the market coupled with growing pharmaceutical & biotechnology industries
Some of the key players in market are GE Healthcare; Shimadzu Corporation; Thermo Fisher Scientific, Inc.; Agilent Technologies; W. R. Grace & Co.-Conn.; Bio-Rad Laboratories, Inc.; Restek Corporation; PerkinElmer, Inc.; Danaher Corporation; and DANI Instruments S.p.A.

U.S. Mechanical Ventilators Market is Anticipated to Register a CAGR of 40.0% till 2027

Unusually high incidence of Covid-19 has led to large gap between demand and supply of mechanical ventilators, to an extent wherein, automotive and other industrial equipment manufacturers have to step in to increase the supply of this life saving device. The U.S. mechanical ventilators market was valued at 1.43 billion in 2019 and anticipated to register a CAGR of 40.0% over the forecast period. As per the Society of Critical Care Medicine, the current stock of hospital ventilators in the U.S. is around 160,000 units in the 2020 Q1. An additional stockpile of 12,700 with SNS (Strategic National Stockpile) would be made available in the grim situations. At the time of writing this article there are nearly 110,000 confirmed COVID-19 cases. Furthermore, as per American Hospital Association, during this pandemic, nearly 960,000 Americans could need artificial ventilation using Mechanical Ventilators. Owing to the aforementioned factors, the mechanical ventilators are experiencing and will experience sudden spike in the demand in coming few months.

The market is evaluated on the basis of product such as critical care, neonatal, transport and portable and others. Critical care and portable ventilators are expected to experience significant demand surge in the coming financial quarters. Manufacturers are bracing up to multiply the production capacity to meet the global rising demand. The key players operating in this space includes Medtronic, Allied Healthcare, GE Healthcare, Ventec Life Systems, Smiths Medical. Medtronic already increased their production by 40% since January 2020. Moreover, automobile manufacturers are offering their assembly lines to aid the ventilators production. For example, Tesla and Medtronic, General Motors and Ventec Life Systems teaming up for the ventilator production.

In a welcome move by the U.S. FDA, which temporarily waived off its enforcement and inspection requirements that would be helpful for cross industry manufactures to fabricate much needed components for ventilators and other critical care equipment. Supportive and timely regulatory policies by the government is anticipated to provide lucrative growth platform for this market in the coming financial year and thereby affecting the growth rate over the forecast year.

Browse Details of Report@ https://www.grandviewresearch.com/industry-analysis/us-mechanical-ventilators-market

As per our analysis, with the combined manufacturing capacity of all the leading players the market could witness an additional influx of around 65,000 units in the next financial quarter. In addition, government organizations are evaluating the possibility of using the veterinary ventilators for human use. In the UK, Animal Health Trust were in talks with the Royal college of Emergency Medicine and NHS (National Health Service) about the possibility of sharing veterinary ventilators to help.

It’s difficult to predict the exact shape of Coronavirus pandemic curve in the U.S. However, looking at the grim situations in the European nations especially Italy, the peak demand for critical care equipment along with the mechanical ventilators and makeshift ventilators is anticipated to soar at exponential rate over the next few months.

Monday 30 March 2020

Non-PVC IV Bags Market: Industry Demand, Sales, Analysis and Forecasts to 2025

The global Non-PVC IV Bags Market size is expected to reach USD 2.29 billion by 2025, according to a new report by Grand View Research, Inc. Globally, increasing demand for safer medical packaging and strict regulations against usage of PVC are the key factors anticipated to boost the demand for non-PVC alternatives. Extensive research and developments for novel alternatives are expected to fuel the growth further.

As per the current market scenario, usage of non-PVC IV bags is limited to fields such as chemotherapy and parenteral nutrition. With the introduction of different types of alternatives such as ethylene vinyl acetate and polypropylene, PVC packaging is anticipated to be replaced by non-PVC alternatives. These materials can be used for specific purposes such as cold/frozen storage and customized mixtures. The non-PVC packaging market is expected to witness lucrative growth during the forecast period owing to the versatility of applications.

Demand for non-PVC plastics is increasing in medical as well as non-medical industries owing to stricter regulations against their usage since their disposal can cause high level of pollution. The changing trend of using non-PVC materials provides a huge scope for growth, thus attracting manufacturers and investors to this market.

The demand for non-PVC IV bags is increasing in parenteral nutrition services. They also have high demand for multichambered bags; as the formulation differs from patient to patient. The scope for customized IV bags providers is anticipated to increase with the development of personalized therapeutic solutions.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/non-pvc-iv-bags-market

Further key findings from the report suggest:

Single chamber bags dominated the market by capturing 64.6% of the total market share in 2016. High usage in IV drips and other mixtures is a principal factor that can be attributed to the large share.
Ethylene vinyl acetate captured the largest share in 2016 and this dominance is expected to continue over the forecast period. Higher safety and utility of its usage in frozen mixtures including in blood banks are expected to have a high impact on the segment growth.
The demand for copolyester ether is expected to showcase highest growth during the forecast period due to advantages such as transparency, durability, and chemical resistance.
North America dominated the non-PVC IV bags market and is expected to dominate throughout the forecast period. On the other hand, Asia Pacific is expected to showcase fastest growth, fueled by factors such as emergence of a large number of local players and increasing foreign direct investment.
Key players include ANGIPLAST PVT. LTD.; RENOLIT; Shanghai Xin Gen Eco-Technologies Co., Ltd; PolyCine GmbH; Jiangxi Sanxin Medtec Co., Ltd.; Kraton Corporation; Pfizer, Inc. (Hospira).; Baxter; and B. Braun Melsungen AG

Thermometer Market | Industry Size, Share, Trends and Analysis Report

The global Thermometer Market size is expected to reach a value of USD 1.5 billion by 2025, based on a new report by Grand View Research, Inc. Growing number of medical conditions requiring accurate measurement of body temperature for deciding the treatment options is expected to enhance demand for thermometers over the forecast period. High prevalence of diseases such as malaria, swine flu, and dengue, which can be diagnosed primarily by observing body temperature is estimated to provide potential growth opportunities for this market in developing countries.

In addition, requirement for maintenance of an environment of specific temperature in various industries such as food, chemicals, and pharmaceuticals is another high rendering driver resulting in increasing demand for digital and infrared temperature measuring devices. Development of devices with technological advancements for accurately measuring minute temperature differences is expected to be a growth booster for this industry. For instance, the Exergen TAT-2000C can be used to measure body temperature by just rolling the device tip over the child’s forehead.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/thermometer-market

Further Key Findings from the Study Suggest:

The mercury-based thermometers segment dominated the overall market in 2016 in terms of revenue share owing to factors such as growing demand for accuracy in temperature measurement and ease in handling
Digital thermometers held more than one-third of the thermometer market share in 2016 in the mercury-free segment due to benefits such as cost-effectiveness, easier analysis of temperature to a tenth of a degree, and beep indication after temperature fluctuations
Other types of mercury-free thermometers such as disposable ones, temperature strips, and gas thermometers are expected to be fastest growing and are collectively expected to grow at a lucrative CAGR
In term of applications, medical fields including hospital, clinics, and primary healthcare centers dominated the overall market in terms of revenue share as of 2016
On the other hand, the industrial application segment is expected to showcase lucrative growth over the forecast period as pharmaceutical, chemical, and biotechnology industries require specific temperature maintenance during various stages of product development
To avoid contamination and degradation of food & beverages and retain the quality of temperature-sensitive eatables, maintenance of a specific temperature is required. Thus, thermometers have applications in the food industry too
Increasing number of health-conscious consumers, established healthcare infrastructure, and increasing demand for disposable thermometers are the key factors attributing for highest revenue generation of the North American region
The Asia Pacific regional market is expected to register significant growth over the forecast period with CAGR of 8.3% owing to emerging economies, growing base of target population, and growing concern for personal health
Some of the key players in this industry include Exergen Corporation, Omron Healthcare, Inc.; TERUMO CORPORATION, Citizen Systems, 3M (Nexcare), Innovo Medical, RADIANT INNOVATION INC., Good Neighbor Pharmacy, and Fairhaven Health, LLC.

Antiviral Drugs Market Outlook and Forecast Report, 2026

The global Antiviral Drugs Market size is expected to reach USD 46.9 billion by 2027, according to a new report by Grand View Research, Inc. It is estimated to register a CAGR of -2.3% over the forecast period. Increasing geriatric population is considered to be the major factor anticipated to drive the demand for efficient treatment of human immunodeficiency virus (HIV) infections.

According to the Centers of Disease Control and Prevention (CDC), nearly half the people diagnosed with HIV in U.S. are aged 50 and older. Furthermore, according to the data published in World Population Prospects: The 2019 Revision, one in six people globally is estimated to be over age of 65 years by 2050. In addition, one in four persons living in Northern America and Europe would be aged 65 years and above by 2050. The number of persons aged 80 years and above is estimated to triple, from 143 million in 2019 to 426 million in 2050. The increasing aging population worldwide would have a direct impact on the healthcare systems, who would have to meet the needs of the aging population. This, in turn, would drive the demand for antiviral drugs, which can be used to treat a range of viral infections.

Presence of pipeline antiviral products for HIV therapeutics is anticipated to drive the market over the forecast period. For instance, ViiV Healthcare is developing Cabotegravir/rilpivirine (long-acting injectable), which is currently under Phase III and are types of NNRTI/ INSTI drug class. In addition,GS-6207 (capsid inhibitor) and vesatolimod (TLR-7 agonist) are being developed by Gilead Sciences and are currently under Phase I trial for the treatment of HIV. Moreover, advancements in epidemiology and growing awareness of viral diseases are expected to result in a high demand for efficient treatment solutions.

According to the CDC, the prevalence of oral herpes (HSV-1) and genital herpes (HSV-2) was 47.8% and 11.9% respectively, from 2015 to 2016. The Herpes Resource Center (HRC) provides public awareness, education, and patient support. Moreover, the Hepatitis B Foundation provides information such as diagnosis, preventive measures, and treatment. Increasing preventive measures with the availability of various vaccines is expected to hinder the market growth over the forecast period.

Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/antiviral-drugs-market

Further key findings from the report suggest:

Reverse transcriptase inhibitors held the largest share in 2019 and is estimated to be the fastest-growing segment over the forecast period as these inhibitors slow down or prevent viral replication
DNA polymerase inhibitors was the second-largest segment in 2019 owing to its effectiveness in combating drug resistance
Generic products are estimated to be the fastest-growing segment over the forecast period owing to increased adoption of generic drugs in developing countries
Hepatitis dominated the application segment in 2019 owing to the availability of various antiviral products for its treatment
HIV is estimated to be the fastest-growing segment over the forecast period due to its increasing prevalence and incidence rate
North America dominated the global antiviral drugs market in 2019 owing to the presence of key players in the region and the availability of a well-established healthcare infrastructure.

Patient Temperature Management Market Outlook and Forecast Report, 2026

The global Patient Temperature Management Market size is anticipated to reach a value of USD 5.0 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% during the forecast period. Rising number of surgeries is anticipated to accelerate the demand for temperature management devices. For instance, open heart surgeries require lowering down the body heat of patients through blood cooling, which helps reduce the risk of post and perioperative surgical complications.

With growing prevalence of cardiac arrest and other chronic cardiac diseases, there is a rising number of surgeries being undertaken. This growth is anticipated to drive the need for patient temperature management, to avoid the adverse effects on brain. Patient warming systems are also used for cancer patients as adjuncts with chemotherapy and radiation therapy for more effective results. Moreover, in neonatal care, newborns are likely to experience temperature fluctuations and hence, they are kept in incubators to maintain their normal body temperature. The aforementioned factors are driving demand for temperature monitoring devices.

With rising demand for conventional warming and cooling devices, there is a growing need for modern temperature management systems. Introduction of a wide range of surface warming and cooling systems by major market players is expected to positively impact the patient temperature management market during the forecast period. The blood and fluid temperature management devices have also evolved over the years and are applied through a catheter by circulating warm or cool saline in the patients’ body.

Browse Details of Report@
https://www.grandviewresearch.com/industry-analysis/patient-temperature-management-market

Further key findings from the study suggest:

Patient warming systems led the market in 2018 due to rise in the number of surgeries, which lower the body temperature of patients due to the use of general anesthesia
Patient cooling systems are anticipated to exhibit a lucrative CAGR over the forecast period due to the introduction of new products like cooling caps and blood and fluid cooling systems
Surgery segment held the largest market share in 2018 due to increasing number of cardiac and gynecological surgeries across the globe
Operating rooms segment is expected to generate huge revenue due to the large number of surgical procedures being performed and the need for temperature management during these surgeries
In 2018, North America led the patient temperature management market due to rising demand for technologically advanced products in this region
Asia Pacific is expected to showcase lucrative growth over the forecast period, due to increasing sedentary lifestyle resulting in cardiac related disorders
Some of the major companies operating in the market include Stryker Corporation; ZOLL Medical Corporation; Cincinnati Sub-Zero Products, LLC; Medtronic, Inc.; 3M Company; Bard Medical, Inc.; and The 37Company

Friday 27 March 2020

Pneumatic Nebulizers Market | Industry Size, Share, Trends and Analysis Report

The global Pneumatic Nebulizers Market size was valued at USD 490.6 million in 2015 and is expected to reach a value of USD 893.9 million by 2025. The expansion is attributed to the increasing geriatric population base along with the growing need for home healthcare portable devices. The introduction of new systems featuring aerosol drug delivery technology with minimal drug wastage is expected to drive the market growth. For instance, in May 2013, Parion Sciences in partnership with Cambridge Consultants developed a technology that delivers tiny saline droplets that infiltrate deep into the lungs. The trans-nasal pulmonary aerosol delivery device currently undergoing clinical trial is intended for the treatment of cystic fibrosis.

Moreover, with the rising rate of hospital admissions and the resultant high expenditure, companies are encouraged to introduce home care devices that enable pre-hospitalization monitoring. Furthermore, the advent of integrated devices has empowered patients and physicians to share and access data on a single platform.

For instance, in March 2016, Philips received 510 (K) clearance for its Care Orchestrator. The cloud-based technology is a clinical management software, which promotes homecare for sleep apnea and respiratory care patients. Moreover, the clinical management system furnishes a single platform combining sleep and respiratory care, providing informatics and workflow intelligence for patients, providers, and payers.

Some of the major players operating include Omron Corporation, Philips Healthcare; PARI Pharma GmbH; GE Healthcare; Allied Healthcare; Becton, Dickinson and Company; Agilent Technologies; Medline Industries, Inc.; and Briggs Healthcare.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/pneumatic-nebulizer-market

Further Key Findings from the Study Suggest:

Vented nebulizers dominated the product type segment in 2015 owing to their high availability and affordable cost. Moreover, industry contributors are introducing new solutions that enable patient data access in one single platform. In November 2015, CareFusion introduced a new respiratory solution at the American Association for Respiratory Care Congress.
North America is estimated to dominate the pneumatic nebulizers market in 2015. The introduction of advanced technological devices and the supportive medical coverage offered in this region is expected to further fuel market growth. For instance, in March 2015, Sunovion Pharmaceuticals, Inc. announced the initiation of Phase III clinical trial for its SUN-101 solution using PARI Pharma’s eFlow nebulizer system for COPD.
Asia Pacific is the fastest growing market owing to its huge aging population base, increasing focus on preventive care, and government initiatives promoting technological innovations. In July 2015, Tribeca Care launched its online healthcare store to supply homecare respiratory products, wherein prominent medical brands such as Philips, Omron, Nidek, Karma, ResMed, and Vissco were brought under one roof.
Sector players are integrating healthcare with technology to improve upon the current patient monitoring devices in the vertical for respiratory diseases. Moreover, increasing awareness around pre-assessment devices has further accelerated the demand for pneumatic nebulizers. In June 2016, Philips introduced the Patient Adherence Management Service at the 2016 SLEEP event to better patient compliance to sleep therapy.

Europe Molecular Diagnostics Market Outlook and Forecast Report, 2024

The Europe Molecular Diagnostics Market is expected to reach USD4.0 billion by 2024, according to a new report by Grand View Research, Inc. Growing geriatric population and the increasing prevalence of neurological and cardiovascular disorders is expected to drive the growth of molecular diagnostics. Moreover, increasing demand for more efficient healthcare delivery to facilitate early diagnostics is further expected to boost market growth.

Rising awareness levels among individuals pertaining to the availability of effective molecular diagnostic tests to determine the presence of genetic disorders is expected to increase the client base for this industry, consequently leading to early diagnosis of disorders in the population.

In addition, with the demand for high levels of accuracy and cost effectiveness of diagnostic procedures, the existent technologies are continually undergoing progressive changes to develop improved and efficient testing tools. Presence of a number of established healthcare facilities coupled with the technological advancements facilitating and expediting accurate disease diagnosis are expected to serve this market as significant drivers fueling growth.

Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/europe-molecular-diagnostics-market

Further key findings from the study suggest:

The overall vertical was dominated by the reagents with their revenue generation estimated at over USD 930.0 million in 2015 owing to their higher usage including formamide, salts, and dextran sulphate or heparin employed in the drug development process to detect disease-related novel biomarkers
Introduction of reagents for technologically advanced instruments are anticipated to attribute towards an attractive growth of reagents segment over the forecast period
Central laboratories held the largest market share of around 60% in 2015 owing to the highly developed healthcare infrastructure and skilled healthcare professionals & staff associated with them.
Point of care is the fastest growing test location segment with an estimated CAGR of over 12.0% over the forecast period. Increasing demand for expedited diagnosis and rapid analysis has led to the growth of this section.
Infectious diseases dominated the market on the basis of application with the largest revenue contribution in 2015 owing to the large test volumes and extensive portfolio of commercialized products in this area.
HIV held the largest market share of around 14.0% in 2015 in the infectious disease segment. Government initiatives being undertaken in Italy and France to create higher awareness about infectious diseases, such as HIV/AIDS and Hepatitis B, are factors responsible for its high market share.
Polymerase chain reaction (PCR) technology dominated the vertical with overall market revenue of over USD 725.0 million, attributable to the increasing application of molecular diagnostics in the field of drug discovery & development and pharmacogenomics
DNA sequencing is estimated to emerge as a profitable market over the forecast period with a CAGR of around 15.0%. With the sweeping technological advancements in the field, DNA sequencing is presently one of the most cost-effective technologies used to decode the genetic cause underlying a range of diseases.
The next generation sequencing technology segment will witness the highest growth rate throughout the forecast period majorly owing to the increasing R&D initiatives for development of novel drugs.
Germany held the largest market share with maximum revenue generation in 2015, which is attributed primarily to its huge elderly population base. Growing geriatric population coupled with decreased immune levels would engender the widespread prevalence of chronic diseases conditions comprising cardiovascular, neurological, and diabetes
The molecular diagnostics sector in the UK is estimated to grow at a faster rate with a CAGR of over 11.0% throughout the forecast period. The presence of sophisticated healthcare infrastructure, higher disposable income, and the increasing R&D intensity are the key factors contributing towards the growth of this sector in the UK.
Some leading companies in the molecular diagnostics sector include Roche Diagnostics, Alere Inc., Cepheid, Hologic, Inc. (Gen Probe), Sysmex Corporation, Abbott Laboratories, Bayer AG, Siemens Healthcare GmbH, Becton, Dickinson and Company, Johnson & Johnson, bioMérieux SA, Dako, Novartis AG (Grifols), Danaher Corporation, Bio-Rad Laboratories, Inc., and Qiagen N.V.
The established players in this vertical are adopting strategies, such as mergers and acquisitions, new product development, expansion activities pertaining to R&D of novel diagnostic products, and strategic collaborations to widen their existent product portfolios